Top

European Journal of Trauma and Emergency Surgery

Published in:

01-10-2021 | Craniotomy | Original Article

Factors influencing the results of surgical therapy of non-acute subdural haematomas

Authors: Opšenák René, Hanko Martin, Snopko Pavol, Varga Kristián, Fejerčák Tomáš, Kolarovszki Branislav

Published in: European Journal of Trauma and Emergency Surgery | Issue 5/2021

Abstract

Purpose

To identify predictive factors with an impact on the outcome of surgical treatment of non-acute subdural haematomas (NASH).

Methods

One hundred eleven patients who underwent an evacuation of 132 NASH by means of burr hole or craniotomy from January 2014 to December 2018 were retrospectively analyzed. We evaluated the impact of factors that could possibly predict the result of surgical treatment. The assessment was focused on the impact of factors, such as age, gender, pre-operative clinical symptoms, timing and extent of surgical procedure, intake of anticoagulants and antiplatelet drugs, morphological type, recurrence, side localization or bilateral occurrence of NASH. Patients’ functional outcome was quantified using the Glasgow Outcome Score (GOS) with a follow-up period of 3 months.

Results

Morphological type of NASH did not have any significant impact on the final GOS. The risk factors associated with less favorable GOS included preoperative intake of anticoagulants and preoperative finding of phatic disorder, quantitative disorder of consciousness and disorientation. Preoperative intake of antiplatelet drugs or anticoagulants and craniotomy were risk factors for postoperative development of a surgically significant acute extracerebral haematoma. The complications occurred significantly more often after a craniotomy when compared to the burr hole evacuation (p = 0.0163), but the incidence of recurrence of NASH was significantly lower (p = 0.0439).

Conclusion

The risk factors for the surgical treatment of NASH included preoperative intake of antithrombotic drugs and evacuation of NASH through craniotomy. Craniotomy resulted in a significantly lower incidence of recurrence.

Santarius T, Kirkpatrick PJ, Kolias AG, et al. Working toward rational and evidence-based treatment of chronic subdural hematoma. Clin Neurosurg. 2010;57:112–22.PubMed

Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev. 2012;35(2):155–69. https://doi.org/10.1007/s10143-011-0349-y.CrossRefPubMed

Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg. 1981;54(5):637–45. https://doi.org/10.3171/jns.1981.54.5.0637.CrossRefPubMed

Murakami H, Hirose Y, Sagoh M, et al. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of trombomodulin in the mechanism. J Neurosurg. 2002;96(5):877–84. https://doi.org/10.3171/jns.2002.96.5.0877.CrossRefPubMed

Weigel R, Schilling L, Schmiedek P. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien). 2001;143(8):811–8.CrossRef

Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001;95(2):256–62. https://doi.org/10.3171/jns.2001.95.2.0256.CrossRefPubMed

Jennet B, Snoek J, Bond MR, et al. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44(4):285–93.CrossRef

Ro HW, Park SK, Jang DK, et al. Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien). 2016;158(1):135–9. https://doi.org/10.1007/s00701-015-2625-z.CrossRefPubMed

Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation. J Neurosurg. 2018;129(5):1143–50. https://doi.org/10.3171/2017.6.JNS17130.CrossRefPubMed

10.

Lee J, Park JH. Clinical characteristics of bilateral versus unilateral chronic subdural hematoma. Korean J Neurotrauma. 2014;10(2):49–544. https://doi.org/10.13004/kjnt.2014.10.2.49.CrossRefPubMedPubMedCentral

11.

Hsieh CT, Su IC, Hsu SK, et al. Chronic subdural hematoma: differences between unilateral and bilateral occurrence. J Clin Neurosci. 2016;34:252–8. https://doi.org/10.1016/j.jocn.2016.09.015.CrossRefPubMed

12.

You W, Zhu Y, Wang Y, et al. Prevalence of and risk factors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien). 2018;160(5):893–9. https://doi.org/10.1007/s00701-018-3513-0.CrossRef

13.

Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma. Turk Neurosurg. 2017;27(5):756–62. https://doi.org/10.5137/1019-5149.JTN.17347-16.1.CrossRefPubMed

14.

Stanisic M, Pripp AH. A reliable grading system for prediction of chronic subdural hematoma recurrence requiring reoperation after initial burr-hole surgery. Neurosurgery. 2017;81(5):752–60. https://doi.org/10.1093/neuros/nyx090.CrossRefPubMedPubMedCentral

15.

Altaf I, Shams S, Vohra AH. Radiolological predictors of recurrence of chronic subdural hematoma. Pak J Med Sci. 2018;34(1):194–7. https://doi.org/10.12669/pjms.341.13735.CrossRefPubMedPubMedCentral

16.

Wang Y, Zhou J, Fan C, et al. Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: a meta-analysis. J Clin Neurosci. 2017;38:79–83. https://doi.org/10.1016/j.jocn.2016.12.001.CrossRefPubMed

17.

Poon MTC, Al-Shahi SR. Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis. Neurosurg Rev. 2018;41(2):439–45. https://doi.org/10.1007/s10143-017-0860-x.CrossRefPubMed

18.

Motoie R, Karashima S, Otsuji R, et al. Recurrence in 787 patients with chronic subdural hematoma: retrospective cohort investigation of associated factors including direct oral anticoagulant use. World Neurosurg. 2018;118:e87–e91. https://doi.org/10.1016/j.wneu.2018.06.124.CrossRefPubMed

19.

Scerrati A, Mangiola A, Rigoni F, et al. Do antiplatelet and anticoagulant drugs modify outcome of patients treated for chronic subdural hematoma? Still a controversial issue. J Neurosurg Sci. 2018. https://doi.org/10.23736/S0390-5616.18.04311-4.CrossRefPubMed

20.

Glancz LJ, Poon MTC, Coulter IC, et al. Does drain position and duration influence outcomes in patients undergoing burr-hole evacuation of chronic subdural hematoma? lessons from a UK Multicenter Prospective Cohort Study. Neurosurgery. 2018. https://doi.org/10.1093/neuros/nyy366.CrossRefPubMedCentral

21.

Goyal RK, Nayak B, Maharshi R, et al. Management of chronic subdural hematoma: burr hole versus twist drill—a prospective study. Asian J Neurosurg. 2018;13(2):319–23. https://doi.org/10.4103/ajns.AJNS_99_16.CrossRefPubMedPubMedCentral

22.

Yan C, Yang MF, Huang YW. A reliable nomogram model to predict the recurrence of chronic subdural hematoma after burr hole surgery. World Neurosurg. 2018;118:e356–e366366. https://doi.org/10.1016/j.wneu.2018.06.191.CrossRefPubMed

23.

You CG, Zheng XS. Postoperative pneumocephalus increases the recurrence rate of chronic subdural hematoma. Clin Neurol Neurosurg. 2018;166:56–60. https://doi.org/10.1016/j.clineuro.2018.01.029.CrossRefPubMed

24.

Haron S, Bogduk N, Hansen M. A retrospective analysis of chronic subdural haematoma recurrence rates following burr hole trephination versus minicraniotomy. J Clin Neurosci. 2019;59:47–50. https://doi.org/10.1016/j.jocn.2018.11.009.CrossRefPubMed

25.

Kocaman U, Yilmaz H. Description of a modified technique (mini craniotomy-basal membranotomy) for chronic subdural hematoma surgery and evaluation of the contribution of basal membranotomy performed as part of this technique to cerebral expansion. World Neurosurg. 2019;122:e1002–e10061006. https://doi.org/10.1016/j.wneu.2018.10.196.CrossRefPubMed

26.

Heringer LC, Sousa UO, Oliveira MF, et al. The number of burr holes and use of a drain do not interfere with surgical results of chronic sudbural hematomas. Arq Neuropsiquiatr. 2017;75(11):809–12. https://doi.org/10.1590/0004-282X20170136.CrossRefPubMed

Title: Factors influencing the results of surgical therapy of non-acute subdural haematomas
Authors: Opšenák René
Hanko Martin
Snopko Pavol
Varga Kristián
Fejerčák Tomáš
Kolarovszki Branislav
Publication date: 01-10-2021
Publisher: Springer Berlin Heidelberg
Keywords: Craniotomy
Anticoagulant
Published in: European Journal of Trauma and Emergency Surgery / Issue 5/2021
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-019-01258-3

At a glance: The STEP trials

Springer Medicine

Factors influencing the results of surgical therapy of non-acute subdural haematomas

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2021

Impact on polytrauma patient prehospital care during the first wave of the COVID-19 pandemic: a cross-sectional study

Major trauma care in Hong Kong and Germany: a trauma registry data benchmark study

Intracranial pressure monitors associated with increased venous thromboembolism in severe traumatic brain injury

Soluble terminal complement activation fragment sC5b-9: a new serum biomarker for traumatic brain injury?

Severe head injury in elderly: 6-year comparison of treatment and outcome between southern Finland and Navarra (Spain)

Biomechanics and clinical outcome after posterior stabilization of mid-thoracic vertebral body fractures: a systematic literature review